[Form 4] DarioHealth Corp. Insider Trading Activity
Steven Nelson, President and CCO of DarioHealth Corp. (DRIO), reported an open-market purchase of common stock on 08/27/2025. The Form 4 shows a purchase of 40,000 shares at $0.53 per share, bringing his reported beneficial ownership to 95,000 shares. The filing identifies Nelson as a director and officer and is signed by him on 08/27/2025.
Steven Nelson, Presidente e CCO di DarioHealth Corp. (DRIO), ha comunicato un acquisto in mercato aperto di azioni ordinarie in data 27/08/2025. Il modulo Form 4 riporta l'acquisto di 40.000 azioni a 0,53 $ ciascuna, portando la sua titolarit脿 beneficiaria dichiarata a 95.000 azioni. L'invio identifica Nelson come amministratore e dirigente ed 猫 firmato da lui il 27/08/2025.
Steven Nelson, presidente y CCO de DarioHealth Corp. (DRIO), inform贸 una compra en mercado abierto de acciones comunes el 27/08/2025. El Formulario 4 muestra la compra de 40.000 acciones a 0,53 $ por acci贸n, elevando su propiedad beneficiaria declarada a 95.000 acciones. La presentaci贸n identifica a Nelson como director y ejecutivo y est谩 firmada por 茅l el 27/08/2025.
鞀ろ嫲敫� 雱姩(Steven Nelson), DarioHealth Corp.(DRIO)鞚� 靷灔 瓴� 斓滉碃靸侅梾毂呾瀯鞛�(CCO)電� 2025雲� 8鞗� 27鞚检棎 瓿店皽鞁滌灔 毵れ垬 靷嫟鞚� 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 欤茧嫻 0.53雼煬鞐� 40,000欤茧ゼ 毵れ垬頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨溂氅�, 攴胳潣 鞁犼碃霅� 鞁れ 靻岇湢甓岇潃 95,000欤茧 歃濌皜頄堨姷雼堧嫟. 氤搓碃靹滊姅 雱姩鞚� 鞚挫偓鞚挫瀽 鞛勳洂鞙茧 鞁濍硠頃橂┌ 2025雲� 8鞗� 27鞚� 攴戈皜 靹滊獏頄堨姷雼堧嫟.
Steven Nelson, pr茅sident et CCO de DarioHealth Corp. (DRIO), a d茅clar茅 un achat sur le march茅 libre d'actions ordinaires le 27/08/2025. Le formulaire 4 indique l'achat de 40 000 actions 脿 0,53 $ chacune, portant sa participation b茅n茅ficiaire d茅clar茅e 脿 95 000 actions. Le d茅p么t identifie Nelson comme administrateur et dirigeant et est sign茅 par lui le 27/08/2025.
Steven Nelson, Pr盲sident und CCO von DarioHealth Corp. (DRIO), meldete am 27.08.2025 einen Kauf von Stammaktien am offenen Markt. Das Formular Form 4 weist den Kauf von 40.000 Aktien zu 0,53 $ pro Aktie aus und erh枚ht sein gemeldetes wirtschaftliches Eigentum auf 95.000 Aktien. Die Einreichung nennt Nelson als Direktor und leitenden Angestellten und ist von ihm am 27.08.2025 unterzeichnet.
- Insider purchase disclosed: 40,000 common shares acquired at $0.53, increasing reported beneficial ownership to 95,000 shares
- None.
Insights
TL;DR: Insider purchased 40,000 shares at $0.53, modestly increasing reported holdings to 95,000 shares.
The transaction is a routine Section 16 filing documenting an insider open-market purchase. At $0.53 per share for 40,000 shares, the reported cash outlay is $21,200. This increases the insider's direct beneficial ownership to 95,000 shares. The disclosure is timely and complete for the single non-derivative transaction reported.
TL;DR: Filing reflects standard insider disclosure with no governance red flags.
The Form 4 identifies the reporting person as President, CCO and director and shows a straightforward purchase (code P). The filing is signed and dated, meeting disclosure requirements. No dispositions, derivative transactions, or indications of 10b5-1 plan usage are reported in this document.
Steven Nelson, Presidente e CCO di DarioHealth Corp. (DRIO), ha comunicato un acquisto in mercato aperto di azioni ordinarie in data 27/08/2025. Il modulo Form 4 riporta l'acquisto di 40.000 azioni a 0,53 $ ciascuna, portando la sua titolarit脿 beneficiaria dichiarata a 95.000 azioni. L'invio identifica Nelson come amministratore e dirigente ed 猫 firmato da lui il 27/08/2025.
Steven Nelson, presidente y CCO de DarioHealth Corp. (DRIO), inform贸 una compra en mercado abierto de acciones comunes el 27/08/2025. El Formulario 4 muestra la compra de 40.000 acciones a 0,53 $ por acci贸n, elevando su propiedad beneficiaria declarada a 95.000 acciones. La presentaci贸n identifica a Nelson como director y ejecutivo y est谩 firmada por 茅l el 27/08/2025.
鞀ろ嫲敫� 雱姩(Steven Nelson), DarioHealth Corp.(DRIO)鞚� 靷灔 瓴� 斓滉碃靸侅梾毂呾瀯鞛�(CCO)電� 2025雲� 8鞗� 27鞚检棎 瓿店皽鞁滌灔 毵れ垬 靷嫟鞚� 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 欤茧嫻 0.53雼煬鞐� 40,000欤茧ゼ 毵れ垬頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨溂氅�, 攴胳潣 鞁犼碃霅� 鞁れ 靻岇湢甓岇潃 95,000欤茧 歃濌皜頄堨姷雼堧嫟. 氤搓碃靹滊姅 雱姩鞚� 鞚挫偓鞚挫瀽 鞛勳洂鞙茧 鞁濍硠頃橂┌ 2025雲� 8鞗� 27鞚� 攴戈皜 靹滊獏頄堨姷雼堧嫟.
Steven Nelson, pr茅sident et CCO de DarioHealth Corp. (DRIO), a d茅clar茅 un achat sur le march茅 libre d'actions ordinaires le 27/08/2025. Le formulaire 4 indique l'achat de 40 000 actions 脿 0,53 $ chacune, portant sa participation b茅n茅ficiaire d茅clar茅e 脿 95 000 actions. Le d茅p么t identifie Nelson comme administrateur et dirigeant et est sign茅 par lui le 27/08/2025.
Steven Nelson, Pr盲sident und CCO von DarioHealth Corp. (DRIO), meldete am 27.08.2025 einen Kauf von Stammaktien am offenen Markt. Das Formular Form 4 weist den Kauf von 40.000 Aktien zu 0,53 $ pro Aktie aus und erh枚ht sein gemeldetes wirtschaftliches Eigentum auf 95.000 Aktien. Die Einreichung nennt Nelson als Direktor und leitenden Angestellten und ist von ihm am 27.08.2025 unterzeichnet.
FAQ
What transaction did Steven Nelson report on the Form 4 for DRIO?
How many shares does Steven Nelson beneficially own after the reported transaction?
What is Steven Nelson's role at DarioHealth Corp. (DRIO)?
Was the Form 4 properly signed and dated?
Does the Form 4 report any derivative transactions or dispositions?
